Avian pathogenic Escherichia coli ΔtonB mutants are safe and protective live-attenuated vaccine candidates

被引:8
|
作者
Holden, Karen M. [1 ]
Browning, Glenn F. [2 ]
Noormohammadi, Amir H. [1 ]
Markham, Philip [2 ]
Marenda, Marc S. [1 ]
机构
[1] Univ Melbourne, Asia Pacific Ctr Anim Hlth, Fac Vet Sci, Werribee, Vic 3030, Australia
[2] Univ Melbourne, Asia Pacific Ctr Anim Hlth, Fac Vet Sci, Parkville, Vic 3052, Australia
关键词
Avian colibacillosis; Live vaccine; TonB; Siderophore transporter; POTENTIAL VACCINE; VIRULENCE FACTORS; STRAIN; SEQUENCE; GENES; IMMUNOGENICITY; CONSTRUCTION; INACTIVATION; SIMILARITIES; AEROBACTIN;
D O I
10.1016/j.vetmic.2014.07.028
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Avian pathogenic Escherichia coli (APEC) cause colibacillosis, a serious respiratory disease in poultry. Most APEC strains possess TonB-dependent outer membrane transporters for the siderophores salmochelin and aerobactin, which both contribute to their capacity to cause disease. To assess the potential of iron transport deficient mutants as vaccine candidates, the tonB gene was deleted in the APEC wild type strain E956 and a Delta fur (ferric uptake repressor) mutant of E956. The growth of the Delta tonB and Delta tonB/Delta fur mutants was impaired in iron-restricted conditions, but not in iron-replete media. Day old chicks were exposed to aerosols of the mutants to assess their efficacy as live attenuated vaccines. At day 18, the birds were challenged with aerosols of the virulent parent strain E956. Both mutants conferred protection against colibacillosis; weight gains and lesion scores were significantly different between the vaccinated groups and an unvaccinated challenged control group. Thus mutation of iron uptake systems can be used as a platform technology to generate protective live attenuated vaccines against extraintestinal E. coli infections, and potentially a range of Gram negative pathogens of importance in veterinary medicine. (C) 2014 Published by Elsevier B.V.
引用
收藏
页码:289 / 298
页数:10
相关论文
共 50 条
  • [1] Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding
    Trimpert, Jakob
    Dietert, Kristina
    Firsching, Theresa C.
    Ebert, Nadine
    Tran Thi Nhu Thao
    Vladimirova, Daria
    Kaufer, Susanne
    Labroussaa, Fabien
    Abdelgawad, Azza
    Conradie, Andele
    Hofler, Thomas
    Adler, Julia M.
    Bertzbach, Luca D.
    Jores, Joerg
    Gruber, Achim D.
    Thiel, Volker
    Osterrieder, Nikolaus
    Kunec, Dusan
    [J]. CELL REPORTS, 2021, 36 (05):
  • [2] TonB is essential for virulence in avian pathogenic Escherichia coli
    Holden, Karen M.
    Browning, Glenn F.
    Noormohammadi, Amir H.
    Markham, Philip F.
    Marenda, Marc S.
    [J]. COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2012, 35 (02) : 129 - 138
  • [3] Genetic stability of live-attenuated Zika vaccine candidates
    Muruato, Antonio E.
    Shan, Chao
    Fontes-Garfias, Camila R.
    Liu, Yang
    Cao, Zengguo
    Gao, Qiang
    Weaver, Scott C.
    Shi, Pei-Yong
    [J]. ANTIVIRAL RESEARCH, 2019, 171
  • [4] A LIVE-ATTENUATED VACCINE FOR THE TREATMENT OF URINARY TRACT INFECTION BY UROPATHOGENIC ESCHERICHIA COLI
    Billips, Benjamin K.
    Yaggie, Ryan E.
    Klumpp, David J.
    Schaeffer, Anthony J.
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 235 - 236
  • [5] A Live-Attenuated Vaccine for the Treatment of Urinary Tract Infection by Uropathogenic Escherichia coli
    Billips, Benjamin K.
    Yaggie, Ryan E.
    Cashy, John P.
    Schaeffer, Anthony J.
    Klumpp, David J.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (02): : 263 - 272
  • [6] Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design
    VanBuskirk, Kelley M.
    O'Neill, Matthew T.
    De la Vega, Patricia
    Maier, Alexander G.
    Krzych, Urszula
    Williams, Jack
    Dowler, Megan G.
    Sacci, John B., Jr.
    Kangwanrangsan, Niwat
    Tsuboi, Takafumi
    Kneteman, Norman M.
    Heppner, Donald G., Jr.
    Murdock, Brant A.
    Mikolajczak, Sebastian A.
    Aly, Ahmed S. I.
    Cowman, Alan F.
    Kappe, Stefan H. I.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (31) : 13004 - 13009
  • [7] Development of Attenuated and Immunogenic Live-attenuated Respiratory Syncytial Virus Vaccine Candidates
    Hornung, Sandra L.
    Tran, Kim C.
    Teng, Michael N.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB120 - AB120
  • [8] Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates
    Santiago, Araceli E.
    Mann, Barbara J.
    Qin, Aiping
    Cunningham, Aimee L.
    Cole, Leah E.
    Grassel, Christen
    Vogel, Stefanie N.
    Levine, Myron M.
    Barry, Eileen M.
    [J]. PATHOGENS AND DISEASE, 2015, 73 (06):
  • [9] An attenuated mutant of avian pathogenic Escherichia coli serovar O78: a possible live vaccine strain for prevention of avian colibacillosis
    Nagano, Tetsuji
    Kitahara, Rie
    Nagai, Shinya
    [J]. MICROBIOLOGY AND IMMUNOLOGY, 2012, 56 (09) : 605 - 612
  • [10] Prophylactic vaccination with a live-attenuated herpes zoster vaccine in lung transplant candidates
    Wang, Lei
    Verschuuren, Erik A. M.
    Paap, Davy
    Rondaan, Christien
    Raveling-Eelsing, Elisabeth
    Westra, Johanna
    Bos, Nicolaas A.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (12): : 1445 - 1454